Skip to content

Study on the correlation between cerebral vasospasm and symptom degree of sphingosine-1-phosphate in patients with aneurysmal subarachnoid hemorrhage

Study on the correlation between cerebral vasospasm and symptom degree of sphingosine-1-phosphate in patients with aneurysmal subarachnoid hemorrhage

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099829
Enrollment
Unknown
Registered
2025-03-31
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aneurysmal subarachnoid hemorrhage

Interventions

Spasm group:No intervention
Non-spasm group:No intervention
control group:No intervention

Sponsors

Department of Neurosurgery, Center people 's hospital of The Three Gorges University (xiling district ), Hubei Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ( 1 ) Patients in the spasm group and the non-spasm group were confirmed to have subarachnoid hemorrhage by head CT or lumbar cone puncture ; ( 2 ) Patients in the spasm group and the non-spasm group were diagnosed with intracranial aneurysms by DSA within 24 hours of admission, and successfully performed at the same time. Interventional embolization of intracranial aneurysms ; ( 3 ) Other patients who need lumbar puncture to check cerebrospinal fluid but without subarachnoid hemorrhage ; ( 4 ) In the control group, no subarachnoid hemorrhage was confirmed by cranial CT or lumbar cone puncture, or no vasospasm and vascular stenosis were found by DSA ; ( 5 ) Hemorrhagic patients with mild disturbance of consciousness, no obvious or only mild focal neurological dysfunction, Hunt-Hess grade. Grade I-III ;

Exclusion criteria

Exclusion criteria: ( 1 ) Traumatic or unexplained subarachnoid hemorrhage caused by non-aneurysmal rupture ; ( 2 ) The Hunt-Hess grade of critical illness was IV-V. ( 3 ) Have serious complications or other systemic diseases. ( 4 ) Have a history of vascular disease ( internal carotid artery stenosis, moyamoya disease, etc. ) ;

Design outcomes

Primary

MeasureTime frame
Sphingosine 1-phosphate;

Secondary

MeasureTime frame
Blood flow velocity of the middle cerebral artery;

Countries

China

Contacts

Public ContactHua Tang

Center people 's hospital of The Three Gorges University (xiling district ), Hubei Province

jian655339zetu@163.com+86 158 7163 8505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026